Safety after COVID-19 Vaccine Authorization
- This publication identifies the Public Health Agency's post-market surveillance system, which is used to monitor the safety and effectiveness of a vaccine once it is authorized for use.
- This page highlights how this system has altered to address the use of COVID-19 vaccines, how the federal government is monitoring the emerging COVID-19 variants with regards to current authorized vaccines, and how to report any vaccine or treatment safety concerns to Health Canada.
Citation
Canada. Public Health Agency of Canada. Vaccines and treatments for COVID-19: Safety after authorization. Government of Canada, 2022. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks/covid-19-vaccine-treatment/safety-after-authorization.html
Overlapping Topics
Health Care
Policy Sub-Topic
Policy Type
Policy Pronouncement